OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
Xiaoqi Li, Xin Wang, Binyu Wang, et al.
Phytomedicine (2022) Vol. 99, pp. 154027-154027
Closed Access | Times Cited: 25

Showing 25 citing articles:

Ginsenoside Rb1 attenuates doxorubicin induced cardiotoxicity by suppressing autophagy and ferroptosis
Yafei Zhai, Jinmeng Bai, Ying Peng, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 710, pp. 149910-149910
Closed Access | Times Cited: 9

Betaine ameliorates doxorubicin‐induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF‐β expression
Sumeet Kumar Singh, Poonam Yadav, D.G. Patel, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 8, pp. 4134-4147
Closed Access | Times Cited: 6

Cardioprotective potentials of myricetin on doxorubicin-induced cardiotoxicity based on biochemical and transcriptomic analysis
Jaili Li, Ting Luo, Yao Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116748-116748
Open Access | Times Cited: 5

The mechanism and therapeutic strategies in Doxorubicin induced cardiotoxicity: Role of programmed cell death
Yanzhao Li, Jing Yan, Pingzhen Yang
Cell Stress and Chaperones (2024)
Open Access | Times Cited: 5

Natural products targeting regulated cell deaths for adriamycin-induced cardiotoxicity
Zheng Wang, Yanli Zhu, Yu Yao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Puerarin activates adaptive autophagy and protects the myocardium against doxorubicin-induced cardiotoxicity via the 14–3-3γ/PKCε pathway
Yian Peng, Liang Wang, Zeyu Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113403-113403
Open Access | Times Cited: 23

Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration
Haiwei Chen, Jianwei Zhou, Guangzhi Zhang, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 23

Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
Ruirui Zhang, Hao Zhang, Houyin Shi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3052-3070
Open Access | Times Cited: 22

Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems
Cheng‐Yi He, Yunfei Chen, Jiao Xie, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

The Dual Function of Autophagy in Doxorubicin-induced Cardiotoxicity: Mechanism and Natural products
Nannan Tan, Hanwen Luo, Weili Li, et al.
Seminars in Cancer Biology (2025)
Closed Access

Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches
Linghua Song, Qingzhuo Qiu, Fei Ju, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110140-110140
Closed Access | Times Cited: 3

Chitosan-derivative nanoparticles loaded with dihydromyricetin: Characterization, antibacterial and antioxidant activities
Chenmiao Zhang, Shijiao Guo, Lihua Ye, et al.
Carbohydrate Polymer Technologies and Applications (2024) Vol. 8, pp. 100532-100532
Open Access | Times Cited: 2

Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPKα2 pathway
Yichen Hu, Jingzhi Yu, Wanxian He, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113078-113078
Closed Access | Times Cited: 2

The Protective Effect of Flavonoids in the Diet on Autophagy-Related Cardiac Impairment
Serena L’Abbate, Claudia Kusmic
Nutrients (2024) Vol. 16, Iss. 14, pp. 2207-2207
Open Access | Times Cited: 1

Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart
Sebastian Korste, Stephan Settelmeier, Lars Michel, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6052-6052
Open Access | Times Cited: 3

Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity
Tianhu Wang, Yan Ma, Shan Gao, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 11, pp. 336-336
Open Access | Times Cited: 2

The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
Cardiovascular Toxicology (2023) Vol. 24, Iss. 2, pp. 146-157
Closed Access | Times Cited: 2

The Role of mTOR in the Doxorubicin-Induced Cardiotoxicity: A Systematic Review
Dareuosh Shackebaei, Mahvash Hesari, Sara Gorgani, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access

Page 1

Scroll to top